Enabling Low-income Seniors Access to Shingles Vaccines

Mr Murali Pillai asked the Minister for Health having regard to the fact that more than 90% of Singaporeans of and above the age of 50 carry dormant varicella-zoster virus and a study in the US suggesting that up to one in three adults can experience the reactivation of the virus in the form of shingles, whether the Government will study ways to enable seniors from low-income backgrounds to have access to shingles vaccines which are currently viewed as expensive.

Mr Ong Ye Kung: The Ministry of Health is currently evaluating the shingles vaccine's clinical and cost-effectiveness, with a view to decide if it should be included in the National Adult Immunisation Schedule (NAIS). If yes, it will be eligible for subsidies and MediSave usage.